Siamab Therapeutics' Series C Round

Siamab Therapeutics raised a round of funding on April 09, 2015. Investors include Boston Harbor Angels.

Siamab Therapeutics, formerly Sialix, is a biopharmaceutical company developing novel cancer immunotherapies. Siamab has developed a platform of technologies that enable the rapid discovery and develo…

Articles about Siamab Therapeutics' Series C Round: